Physician profile
Lora E Hailey
NPI 1952651655
$8,379.33
in general payments reported to CMS, 2019-2025
36 companies · $1,658 in 2025
The $1,658 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,086 · 2022: $857 · 2023: $1,863 · 2024: $2,915 · 2025: $1,658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,555 · Travel and Lodging: $881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,554.94 |
| Travel and Lodging | $881.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,906.39 | 2021-2025 | Watchman Flx, Watchman Access System, Bodyguardian |
| Novartis Pharmaceuticals Corporation | $905.32 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $710.11 | 2021-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $589.54 | 2021-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $536.62 | 2021-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals Lp | $482.86 | 2021-2025 | Farxiga, Wainua, Andexxa |
| United Therapeutics Corporation | $389.42 | 2022-2025 | Tyvaso, Tyvaso |
| Pfizer INC. | $357.42 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $319.11 | 2022-2025 | Verquvo, Winrevair |
| Lexicon Pharmaceuticals, INC. | $226.99 | 2023-2024 | Inpefa |
| Bayer Healthcare Pharmaceuticals INC. | $216.99 | 2025 | |
| Amgen INC. | $201.18 | 2021-2024 | Repatha |
| Novo Nordisk INC | $184.93 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $169.99 | 2021-2025 | Lifevest |
| Baxter Healthcare | $140.67 | 2023 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $125.42 | 2022-2025 | Amvuttra |
| Abbott Laboratories | $101.73 | 2021-2024 | Cardiomems, Amplatzer Amulet, Merlin@Home |
| Kiniksa Pharmaceuticals International, Plc | $84.73 | 2024 | Arcalyst |
| Amarin Pharma, INC. | $80.08 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $77.43 | 2025 | Assure Wcd |
| Irhythm Technologies, INC. | $77.25 | 2022-2023 | Zio Xt Patch |
| Actelion Pharmaceuticals US, INC. | $67.40 | 2021-2025 | Opsumit, Uptravi |
| Scpharmaceuticals INC. | $61.41 | 2023-2025 | |
| Lilly USA, LLC | $48.19 | 2025 | Mounjaro, Zepbound |
| Bridgebio Pharma, INC. | $38.05 | 2025 | Attruby |
| Astellas Pharma US INC | $35.46 | 2021 | |
| Inspire Medical Systems, INC. | $34.98 | 2025 | Inspire |
| Sanofi-Aventis U.S. LLC | $33.22 | 2023-2024 | |
| Esperion Therapeutics, INC. | $33.17 | 2021 | |
| Vital Connect, INC | $32.56 | 2024 | Vitalpatch Rtm |
| Preventice Services, LLC | $25.28 | 2021 | |
| Medtronic, INC. | $20.94 | 2021 | |
| Kiniksa Pharmaceuticals, Ltd. | $19.44 | 2023 | Arcalyst |
| Daiichi Sankyo INC. | $16.57 | 2025 | Injectafer |
| Biosense Webster, INC. | $14.38 | 2025 | Carto 3 |
| Philips North America LLC | $14.10 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lora Hailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.